The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 178 of the 179 references it cites were found in a registry or an index.
Abstract
Cholinergic synapses are ubiquitous in the human central nervous system. Their high density in the thalamus, striatum, limbic system, and neocortex suggest that cholinergic transmission is likely to be critically important for memory, learning, attention and other higher brain functions. Several lines of research suggest additional roles for cholinergic systems in overall brain homeostasis and plasticity. As such, the brain's cholinergic system occupies a central role in ongoing research related to normal cognition and age-related cognitive decline, including dementias such as Alzheimer's disease. The cholinergic hypothesis of Alzheimer's disease centres on the progressive loss of limbic and neocortical cholinergic innervation. Neurofibrillary degeneration in the basal forebrain is believed to be the primary cause for the dysfunction and death of forebrain cholinergic neurons, giving rise to a widespread presynaptic cholinergic denervation. Cholinesterase inhibitors increase the availability of acetylcholine at synapses in the brain and are one of the few drug therapies that have been proven clinically useful in the treatment of Alzheimer's disease dementia, thus validating the cholinergic system as an important therapeutic target in the disease. This review includes an overview of the role of the cholinergic system in cognition and an updated understanding of how cholinergic deficits in Alzheimer's disease interact with other aspects of disease pathophysiology, including plaques composed of amyloid-β proteins. This review also documents the benefits of cholinergic therapies at various stages of Alzheimer's disease and during long-term follow-up as visualized in novel imaging studies. The weight of the evidence supports the continued value of cholinergic drugs as a standard, cornerstone pharmacological approach in Alzheimer's disease, particularly as we look ahead to future combination therapies that address symptoms as well as disease progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The FDA approved two anti-amyloid immunotherapies, lecanemab and donanemab, for “early-stage” AD, encompassing both stage 3 (MCI) and stage 4 (mild dementia).”
From A 2025 update on treatment strategies for the Alzheimer’s disease spectrum (2025) · cites this paper as [18]
In the citing paper
“Degeneration of cholinergic neurons is known to significantly contribute to cognitive decline in AD patients [132] and has been studied in a variety of genetic AD mouse models.”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [132]
In the citing paper
“AChE contributes to acetylcholine depletion and may facilitate the formation of neurotoxic Aβ-AChE complexes38.”
From Small-molecule PCSK9 inhibition enhances BBB amyloid-β clearance and suppresses microglial inflammation in Alzheimer’s disease models (2026) · cites this paper as [38]
In the citing paper
“Cholinergic deficit also alters the permeability of the blood brain barrier causing erroneous transportation of metabolites and hampering the removal of amyloid plaque, worsening the disease condition [8].”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [8]
In the citing paper
“From this point of view, AD could be prevented or effectively treated by decreasing the production of Aβ and tau; preventing aggregation or misfolding of these proteins; neutralizing or removing the toxic aggregate or misfolded forms of these proteins; or a combination of these modalities.7”
From Current and Future Treatments in Alzheimer Disease: An Update (2020) · cites this paper as [7]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
Perry, E. K., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P. H., & Perry, R. H. (1978) · BMJ · doi:10.1136/bmj.2.6150.1457 · Cited by 2,042
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Human Memory and the Cholinergic System: A Relationship to Aging?
Drachman, D. A. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490320001001 · Cited by 1,397
NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIES
BOWEN, D. M., SMITH, C. B., WHITE, P., & DAVISON, A. N. (1976) · Brain · doi:10.1093/brain/99.3.459 · Cited by 1,311
Research works printed but not linked: 1
- Geula, 1994, Cholinergic systems and related neuropathological predilection patterns in Alzheimer disease, 263
Cited by
Items 701–800 of 1,002
Kokkali, M., Karali, K., Thanou, E., Παπαδοπούλου, Μ., Zota, I., Tsimpolis, A., Efstathopoulos, P., Calogeropoulou, T., Li, K. W., Sidiropoulou, K., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02833-w · Cited by 15
Glaucoma: Biological Mechanism and its Clinical Translation
Durán‐Cristiano, S. C. (2022) · Current Molecular Medicine · doi:10.2174/1566524022666220508182051 · Cited by 15
Adaptive immunity in the neuroinflammation of Alzheimer’s disease
Liu, H., Chen, Y., Zhang, J., & Chen, X. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003695 · Cited by 15
Oddsson, S., Kowal, N. M., Ahring, P. K., Ólafsdóttir, E. S., & Balle, T. (2020) · Molecules · doi:10.3390/molecules25122872 · Cited by 15
Borroni, V., Kamerbeek, C. B., Pediconi, M. F., & Barrantes, F. J. (2020) · Molecules · doi:10.3390/molecules25204838 · Cited by 15
Schurad, B., Koch, C., Schug, B. S., Morte, A., Vaqué, A., de la Torre, R., & Iniesta, M. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220823105059 · Cited by 15
Köse, S., Kutlu, M. D., Kara, S., Polat, S., & Akıllıoğlu, K. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148429 · Cited by 15
Temporal dynamics of cholinergic activity in the septo-hippocampal system
Kopsick, J. D., Hartzell, K., Lazaro, H., Nambiar, P., Hasselmo, M. E., & Dannenberg, H. (2022) · Frontiers in Neural Circuits · doi:10.3389/fncir.2022.957441 · Cited by 15
Yusof, N. I. S. M., & Fauzi, F. M. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105738 · Cited by 15
Hazar‐Yavuz, A. N., Yildiz, S., KELEŞ, R., Çam, M. E., & Kabasakal, L. (2022) · Journal of Research in Pharmacy · doi:10.29228/jrp.128 · Cited by 15
Anesthesia and dementia: An up-to-date review of the existing literature
Tsolaki, M., Sia, E., & Giannouli, V. (2022) · Applied Neuropsychology Adult · doi:10.1080/23279095.2022.2110871 · Cited by 15
Zaręba, P., Łątka, K., Mazur, G., Gryzło, B., Pasieka, A., Godyń, J., Panek, D., Skrzypczak-Wiercioch, A., Höfner, G. C., Latacz, G., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115832 · Cited by 15
Mezeiová, E., Prchal, L., Hrabinová, M., Múčková, Ľ., Pulkrabkova, L., Soukup, O., Misiachna, A., Janoušek, J., Fibigar, J., Kucera, T., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116399 · Cited by 15
Therapeutic Potential of Nelumbo nucifera (Sacred Lotus) in CNS Disorders
Mitra, K., Raihan, M. A., Rahman, M. A., Rouf, R., Reza, H. M., Uddin, S. J., & Muhammad, I. (2022) · Dhaka University Journal of Pharmaceutical Sciences · doi:10.3329/dujps.v20i3.59800 · Cited by 15
Sudeep, H. V., Raj, A., Gouthamchandra, K., Chandrappa, S., & Shyamprasad, K. (2020) · SAGE Open Medicine · doi:10.1177/2050312120973499 · Cited by 15
Col, O. F., Merde, İ. B., Türkmenoğlu, B., & Uysal, M. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.132970 · Cited by 15
Refaay, D. A., Abdel-Hamid, M. I., Alyamani, A. A., Abdel‐Mogib, M., Ahmed, D. M., Negm, A., Mowafy, A. M., Ibrahim, A. A., & Mahmoud, R. M. (2022) · Plants · doi:10.3390/plants11060735 · Cited by 15
Cheon, H. J., Nguyen, Q. H., & Kim, M. I. (2021) · Nanomaterials · doi:10.3390/nano11051207 · Cited by 15
Volonté, C., Hu, G., Shaw, C. A., Claudio, V. J., dos Santos, J. A., Vaz, S. H., Sebastião, A. M., Balcar, V. J., Mozley, P. D., Verde, F., et al. (2026) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2026.1004136 · Cited by 14
Pharmacokinetic evaluation of donanemab for the treatment of Alzheimer’s
Song, T., Wang, Y., Silverglate, B., & Grossberg, G. T. (2024) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2024.2357637 · Cited by 14
Self-citationThe Pathogenesis in Alzheimer's Disease: TREM2 as a Potential Target
Liu, G., Zhang, L., Fan, Y., & Ji, W. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2206150 · Cited by 14
Almheiri, R. T., Hajjar, B. M., Alkhaaldi, S. M. I., Rabeh, N., Aljoudi, S., Abd‐Elrahman, K. S., & Hamdan, H. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06201-2 · Cited by 14
Llorente‐Ovejero, A., Martínez‐Gardeazabal, J., Moreno‐Rodríguez, M., Lombardero, L., Román, E. G. D. S., Manuel, I., Giralt, M. T., & Rodríguez‐Puertas, R. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00169 · Cited by 14
Håkansson, S., Karlander, M., Larsson, D., Mahamud, Z., Ptacek, S. G., Zelezniak, A., & Zelano, J. (2021) · Epilepsia · doi:10.1111/epi.16987 · Cited by 14
Goswamee, P., & McQuiston, A. R. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00267 · Cited by 15
Fisher, R., Matheny, L., Ankeny, S. E., Qin, L., Coleman, L. G., & Vetreno, R. P. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1531628 · Cited by 14
Potential therapeutic natural compounds for the treatment of Alzheimer's disease
Huang, Q., Wu, W., Wen, Y., Lu, S., & Zhao, C. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155822 · Cited by 14
Rosales‐Hernández, M. C., Valdez, M. O., Toledano, J. V., Wejebe, J. E. M., Morales, L. G. F., & Cruz, A. (2024) · Molecules · doi:10.3390/molecules29194780 · Cited by 14
Murayama, M. A., Arimitsu, N. N., Shimizu, J., Fujiwara, N., Takai, K., Okada, Y., Hirotsu, C., Takada, E., Tomoko, S., & Suzuki, N. (2021) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.21-0008 · Cited by 14
Afolabi, O. B., Olasehinde, O. R., Owolabi, O. V., Jaiyesimi, K. F., Adewumi, F. D., Idowu, O. T., Mabayoje, S. O., Obajuluwa, A. O., & Akpor, O. B. (2024) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-024-04424-2 · Cited by 14
Uras, G., Manca, A., Zhang, P., Markus, Z., Mack, N. A., Allen, S., Bo, M., Xu, S., Xu, J., Γεωργίου, Μ., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.691222 · Cited by 14
A cognitive–motor framework for spatial navigation in aging and early-stage Alzheimer's disease
Hill, P. F., & Ekstrom, A. D. (2025) · Cortex · doi:10.1016/j.cortex.2025.02.003 · Cited by 14
Liu, D., Hsueh, S., Tweedie, D., Price, N., Glotfelty, E. J., Lecca, D., Telljohann, R. S., de Cabo, R., Hoffer, B. J., & Greig, N. H. (2024) · Brain Communications · doi:10.1093/braincomms/fcae204 · Cited by 14
Neuronal and Glial α7 Nicotinic Acetylcholine Receptors: Role in Alzheimer’s Disease Pathophysiology
Rennie, K. (2025) · Life · doi:10.3390/life15071032 · Cited by 14
Zadrożny, M., Drapich, P., Gąsiorowska, A., Niewiadomski, W., Harrington, C. R., Wischik, C. M., Riedel, G., & Niewiadomska, G. (2024) · Cells · doi:10.3390/cells13070642 · Cited by 14
Toward a Multimodal Computer-Aided Diagnostic Tool for Alzheimer’s Disease Conversion
Pena, D., Suescun, J., Schiess, M., Ellmore, T. M., Giancardo, L., & Initiative, T. A. D. N. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.744190 · Cited by 14
Li, H., Chen, Z., Shen, Y., Xiong, T., Chen, A., Chen, L., Ye, Y., Jiang, Q., Zhang, Y., Sun, J., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05571-3 · Cited by 14
dos Santos, A., Teixeira, F. C., da Silva, D. S., Veleda, T. A., de Mello, J. E., Luduvico, K. P., Tavares, R. G., Stefanello, F. M., Cunico, W. J., & Spanevello, R. M. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.11.015 · Cited by 14
Pluta, R. M., Miziak, B., & Czuczwar, S. J. (2023) · Molecules · doi:10.3390/molecules28155624 · Cited by 14
The Dual Role of Astrocyte-Derived Exosomes and Their Contents in the Process of Alzheimer’s Disease
Liu, Z., Zhang, H., Liu, S., Hou, Y., & Chi, G. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220698 · Cited by 14
Saleem, U., Chauhdary, Z., Islam, S., Zafar, A., Khayat, R. O. S., Althobaiti, N. A., Shah, G. M., Alqarni, M. A., & Shah, M. A. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01046-w · Cited by 14
Wu, J., Zhang, H., Wang, Y., Yin, G., Li, Q., Zhuo, L., Chen, H., & Wang, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1036030 · Cited by 14
Конвергенция концепций патогенеза болезни Альцгеймера
Kozin, S. A., & Makarov, A. А. (2019) · Molecular Biology · doi:10.1134/s0026898419060107 · Cited by 14
Lykhmus, O., Tzeng, W.-Y., Koval, L., Uspenska, K., Zirdum, E., Kalashnyk, O., Garaschuk, O., & Skok, M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117255 · Cited by 14
Ghaffar, U., Batool, Z., Tasleem, M., Sadeghian, N., Taslımı, P., Mali, S. N., Dahlous, K. A., Jawarkar, R. D., Gurav, S. S., Zhao, X., et al. (2025) · Archiv der Pharmazie · doi:10.1002/ardp.70034 · Cited by 14
Gujral, S. S., Shakeri, A., Hejazi, L., & Rao, P. P. N. (2022) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2022.100075 · Cited by 14
Kumar, Y., & Xu, B. (2025) · Food Chemistry · doi:10.1016/j.foodchem.2025.145583 · Cited by 14
Ren, T., Chen, Z. B., Xie, J., Tan, S., & Zhu, Y. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106046 · Cited by 14
Antonazzo, B., Marano, G., Romagnoli, E., Ronzoni, S., Frati, G., Sani, G., Janiri, L., & Mazza, M. (2020) · Minerva Cardiology and Angiology · doi:10.23736/s0026-4725.20.05452-3 · Cited by 14
Mizuno, S., Kurobe-Takashima, Y., Kuriki, D., Susaki, K., Otsuka, K., Tsuchihashi, T., Abe, K., & Kobayashi, S. (2025) · PLoS ONE · doi:10.1371/journal.pone.0328206 · Cited by 14
Effect of Different Vitamin D Levels on Cognitive Function in Aged Mice After Sevoflurane Anesthesia
Zhang, J., Zhang, X., Yang, Y., Zhao, J. L., Hu, W., & Yu, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.940106 · Cited by 14
Koya, P. C., Kolla, S. C., Madala, V., & Sayana, S. B. (2025) · Cureus · doi:10.7759/cureus.85814 · Cited by 14
Nakamura, Y., Kim, R., Nishiyama, K., Kikuchi, T., Ishikawa, I., & Aoki, H. (2023) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14566 · Cited by 14
A Chronological Review of Potential Disease-Modifying Therapeutic Strategies for Alzheimer’s Disease
Ettcheto, M., Busquets, O., Espinosa-Jiménez, T., Verdaguer, E., Auladell, C., & Camins, A. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200211121416 · Cited by 13
TM2D genes regulate Notch signaling and neuronal function in Drosophila
Salazar, J. L., Yang, S.-A., Lin, Y. Q., Li-Kroeger, D., Marcogliese, P. C., Deal, S. L., Neely, G. G., & Yamamoto, S. (2021) · PLOS Genetics · doi:10.1371/journal.pgen.1009962 · Cited by 13
Alzheimer's disease approaches - Focusing on pathology, biomarkers and clinical trial candidates
Hroudová, J., & Fišar, Z. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111069 · Cited by 13
Liu, Y., Song, S., Li, X., Wang, J., Bao, Y., Wang, X., Lian, L., Liu, X., & Ma, W. (2024) · Pharmaceuticals · doi:10.3390/ph17091231 · Cited by 13
Zeng, Q., Qiu, T., Li, K., Luo, X., Wang, S., Xu, X., Liu, X., Hong, L., Li, J., Huang, P., et al. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103256 · Cited by 13
Caring for Individuals with Alzheimer’s Disease: A Spotlight on Hispanic Caregivers
Garcia, R. I., Khemka, S., Roghani, A. K., Reddy, R. P., Pattoor, V., Jacob, M., Reddy, A. P., Sehar, U., & Reddy, P. H. (2024) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-240035 · Cited by 13
Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer’s drug candidates
Leuci, R., Simić, S., Carrieri, A., Chaves, S., Spada, G. L., Brunetti, L., Tortorella, P., Loiodice, F., Laghezza, A., Catto, M., et al. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107895 · Cited by 13
ten Donkelaar, H. J., Insausti, R., van Domburg, P., Küsters, B., Hashizume, Y., & Hori, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-41878-6_14 · Cited by 13
Zhao, Y., Wu, K., Luo, W., Zhao, Y., Zeng, J., Wu, J., Yang, C., Yang, M., Liu, J., Lei, Z., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118071 · Cited by 13
Dimeric Tacrine(10)-hupyridone as a Multitarget-Directed Ligand To Treat Alzheimer’s Disease
Xuan, Z., Gu, X., Yan, S., Xie, Y., Zhou, Y., Zhang, H., Jin, H., Hu, S., Mak, S., Zhou, D., et al. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00182 · Cited by 13
Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer’s Disease
Yoo, H. S., Kim, H., Lee, J., Chun, J., Lee, H. S., Grothe, M. J., Teipel, S. J., Cavedo, E., Vergallo, A., Hampel, H. J., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230975 · Cited by 13
Self-citationHypocretin/orexin influences chronic sleep disruption injury in the hippocampus
Nick, H., Fenik, P., Zhu, Y., & Veasey, S. C. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1025402 · Cited by 13
Kim, M., Kwon, H., Sohn, S., Lee, W. J., Cho, K., & Kim, G. W. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251391820 · Cited by 13
The Microbiome–Neurodegeneration Interface: Mechanisms, Evidence, and Future Directions
Böckels, L., Alexa, D., Antal, D. C., Gațcan, C., Alecu, C., Kacani, K., Cretu, R. A., Piseru, E.-A., Bîlcu, R. V., & Cuciureanu, D. I. (2026) · Cells · doi:10.3390/cells15020135 · Cited by 13
Zajonz, T. S., Kunzemann, C., Schreiner, A., Beckert, F., Schneck, E., Boening, A., Markmann, M., Sander, M., & Koch, C. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12165245 · Cited by 13
Microorganism-Derived Molecules as Enzyme Inhibitors to Target Alzheimer’s Diseases Pathways
Nguyen, T. H., Wang, S., & Nguyen, V. B. (2023) · Pharmaceuticals · doi:10.3390/ph16040580 · Cited by 13
Shi, A., Long, Y., Ma, Y., Yu, S., Li, D., Deng, J., Wen, J., Li, X., Wu, Y., He, X., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1104269 · Cited by 13
Development of nano Bio LC columns for the search of acetylcholinesterase molecular targets
André, C., & Guillaume, Y. C. (2022) · Journal of Separation Science · doi:10.1002/jssc.202200047 · Cited by 13
IUPHAR review: Moving beyond dopamine-based therapeutic strategies for schizophrenia
Moran, P. M., & Granger, K. T. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107727 · Cited by 13
Li, J., Liu, Y., Yin, C., Zeng, Y., & Mei, Y. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102468 · Cited by 13
Neuroprotective and probiotic potential of Lactiplantibacillus plantarum AM2 in cognitive impairment
Lotfy, W. A., Ali, A. M., Abdou, H. M., & Ghanem, K. M. (2025) · Scientific Reports · doi:10.1038/s41598-025-06103-9 · Cited by 13
Hu, Y., Zhang, Y., Ren, R., Dammer, E. B., Xie, X., Chen, S., Huang, Q., Huang, W., Zhang, R., Chen, H., et al. (2021) · Aging Cell · doi:10.1111/acel.13454 · Cited by 13
Abdullaha, M., Banoo, R., Nuthakki, V. K., Sharma, M. K., Kaur, S., Thakur, S., Kumar, A., Jadhav, H. R., & Bharate, S. B. (2023) · ACS Omega · doi:10.1021/acsomega.2c08167 · Cited by 13
Vardalakis, N., Aussel, A., Rougier, N. P., & Wagner, F. B. (2024) · eLife · doi:10.7554/elife.87356 · Cited by 13
Weishaupt, A.-K., Kubens, L., Ruecker, L., Schwerdtle, T., Aschner, M., & Bornhorst, J. (2023) · Molecules · doi:10.3390/molecules28145373 · Cited by 13
Gupta, M. L., Kumar, A., Prasun, C., Nair, M. S., Kini, S. G., Yadav, D., & Nain, S. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2106515 · Cited by 13
Njan, A. A., Olaleye, E. O., Afolabi, S. O., Anoka-Ayembe, I., Gyebi, G. A., Nyamngee, A., Okeke, U. N., Olaoye, S. O., Alabi, F. M., Adeleke, O. P., et al. (2023) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2023.101261 · Cited by 13
Longitudinal trajectories of basal forebrain volume in normal aging and Alzheimer’s disease
Xia, Y., Maruff, P. T., Doré, V., Bourgeat, P., Laws, S. M., Fowler, C. J., Rainey‐Smith, S. R., Martins, R. N., Villemagne, V. L., Rowe, C. C., et al. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.09.002 · Cited by 13
Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A1 Antagonists
Val, C., Rodríguez-García, C., Prieto‐Díaz, R., Crespo, A., Azuaje, J., Carbajales, C., Majellaro, M., Díaz‐Holguín, A., Brea, J. M., Loza, M. I., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01636 · Cited by 13
Chiriapkin, A., Kodonidi, I. P., Pozdnyakov, D. I., & Glushko, A. A. (2022) · Chimica Techno Acta · doi:10.15826/chimtech.2022.9.2.04 · Cited by 13
Panova, E. V., & Safin, D. A. (2025) · Computational and Theoretical Chemistry · doi:10.1016/j.comptc.2025.115082 · Cited by 13
Bhatta, A., Upadhyaya, J., Chamlagai, D., Dkhar, L., Phanrang, P. T., Kollipara, M. R., & Mitra, S. (2023) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2023.123669 · Cited by 13
Thakur, A., Rana, M., Vanjani, S., Liou, K.-C., Taliyan, R., Nepali, K., & Yang, C. (2026) · Medicinal Research Reviews · doi:10.1002/med.70047 · Cited by 12
Neuroprotective effects of flavonoids
Taghizadieh, M., Modiri, N., Salmaninejad, A., Khayami, R., Taheri, F., Moghoofei, M., Khatami, A., Azhdari, S., Bayat, M., Samadi-khouzani, A., et al. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824467-8.00016-4 · Cited by 12
Qi, G., & Feldmeyer, D. (2022) · Frontiers in Neural Circuits · doi:10.3389/fncir.2022.843025 · Cited by 12
Cholinergic cognitive enhancer effect of Salvia triloba L. essential oil inhalation in rats
ERTOSUN, G. B., Ergen, M., Bardakçı, H., Barak, T. H., & Süyen, G. G. (2023) · Marmara medical journal · doi:10.5472/marumj.1368345 · Cited by 12
Marques, C. S., López, Ó., Leitzbach, L., Fernández‐Bolaños, J. G., Stark, H., & Burke, A. J. (2022) · Synthesis · doi:10.1055/s-0041-1737343 · Cited by 12
Khan, Z., Mehan, S., & Gupta, G. D. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157448 · Cited by 12
Zhang, H., Chen, H., Pei, H., Wang, H., Ma, L., & Li, H. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/4778163 · Cited by 13
Lee, J. H., Song, G. J., Hwang, H. S., & Lee, C. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125653 · Cited by 13
Somatostatin and Astroglial Involvement in the Human Limbic System in Alzheimer’s Disease
González-Rodríguez, M., Astillero‐Lopez, V., Villanueva‐Anguita, P., Paya-Rodriguez, M. E., Flores‐Cuadrado, A., Villar‐Conde, S., Úbeda‐Bañón, I., Martínez-Marcos, A., & Saiz‐Sánchez, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168434 · Cited by 12
Development of novel rivastigmine derivatives as selective BuChE inhibitors for the treatment of AD
Li, Y., Zhang, Q., Wang, X., Liu, Z., Chen, H., Xu, Y., Xu, Y., Zhang, W., Du, Y., Tan, Z., et al. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108245 · Cited by 12
Mello-Hortega, J. V., Oliveira, C. S.-D., Araújo, V. E. S. D., Alle, L. F., Tureck, L. V., & de Souza, R. L. R. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70229 · Cited by 12
Rong, K., Li, Z., Wu, X., Gao, S., Zhao, J. V., Yang, J., Jiang, X., Zhang, J., & Tang, W. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117003 · Cited by 12
Pasieka, A., Panek, D., Zaręba, P., Sługocka, E., Gucwa, N., Espargaró, A., Latacz, G., Khan, N., Bucki, A., Sabaté, R., et al. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117333 · Cited by 12
Zhang, X., Huang, S., Xu, H., Hu, Y., & Gao, L. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1666082 · Cited by 12
Svobodová, B., Pulkrabkova, L., Panek, D., Misiachna, A., Kolcheva, M., Andrýs, R., Handl, J., Čapek, J., Nyvltová, P., Roušar, T., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119124 · Cited by 12
Metadata
- Authors
- Hampel, H., Mesulam, M.-M., Cuello, A. C., Farlow, M. R., Giacobini, E., Grossberg, G. T., Khachaturian, A. S., Vergallo, A., Cavedo, E., Snyder, P. J., & Khachaturian, Z. S.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Northwestern University (US)
- McGill University (CA)
- Indiana University School of Medicine (US)
- University Hospital of Geneva (CH)
- Saint Louis University (US)
- Prevent Alzheimer’s Disease 2020 (US)
- University of Rhode Island (US)
- Corresponding author
- Hampel, Harald
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-05-29
- Volume
- 141
- Issue
- 7
- Pages
- 1917-1933
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC6022632
- OpenAlex
- W2805257646
- Cited by
- 1,918
- References
- 179
- Citations by year
- 2026: 245 · 2025: 298 · 2024: 298 · 2023: 328 · 2022: 300 · 2021: 228 · 2020: 130 · 2019: 65 · 2018: 21
- FWCI
- 14.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Brain (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Purdue University Indianapolis (Indiana University) (submittedVersion)
- Funders
- AXA Research Fund
- ‘Fondation pour la Recherche sur Alzheimer’, Paris, France. Ce travail a bénéficié d'une aide de l’Etat ‘Investissements d’avenir’ (ANR-10-IAIHU-06)
- ‘Investissements d’avenir’ (ANR-10-IAIHU-06)
- Canadian Institutes of Health Research
- National Research Council
- Alzheimer Society of Canada
- Rotary Club Livorno ‘Mascagni’/The Rotary Foundation (GG1758249)
- ADC (AG013854)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, cholinergic system, cholinergic hypothesis, cholinesterase inhibitors, acetylcholine, cholinergic denervation, neurofibrillary degeneration, amyloid plaques, cognitive decline, cholinergic drugs, combination therapy
- MeSH terms
- Alzheimer Disease, Cholinesterase Inhibitors, Cognition, Cognition Disorders, Humans, Amyloid beta-Peptides, Neurofibrillary Tangles, Cholinergic Agents, Cholinergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.